MillerKnoll (MLKN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 Jan, 2026Executive summary
Q2 FY2026 net sales were $955.2 million, down 1.6% year-over-year, while orders increased 5.5% to $972.5 million; organic sales declined 2.5% and organic orders rose 4.5%.
Adjusted EPS for Q2 FY2026 was $0.43, down 21.8% year-over-year; reported EPS was $0.35, down from $0.49 last year.
Gross margin improved by 20 basis points to 39.0%, driven by favorable product/channel mix and price increases.
Operating margin was 5.1%, down from 6.4% last year; adjusted operating margin was 5.9%.
Order growth was solid in every segment, with notable momentum in retail and contract businesses.
Financial highlights
Six-month net sales were $1,910.9 million, up 4.3% year-over-year; net earnings attributable to shareholders were $44.4 million, up 35%.
Adjusted EBITDA for FY25 was $359.8 million, down from $381.3 million in FY24.
Free cash flow for FY25 was $101.7 million, a decrease from $273.9 million in FY24.
Cash at Q2 FY26 was $180 million; long-term debt stood at $1,321 million; liquidity at quarter-end was $548.3 million.
Net debt-to-EBITDA ratio at 2.87x, below lending covenant limits.
Outlook and guidance
Q3 FY2026 net sales expected between $923 million and $963 million, with gross margin guidance of 37.9% to 38.9%.
Adjusted diluted EPS for Q3 expected between $0.42 and $0.48.
Full-year capital expenditures projected at $120 million–$130 million, focused on facilities and sustainability.
Guidance reflects seasonal softness in contract business and Chinese New Year timing.
Proactive pricing and tariff mitigation expected to offset tariff impacts in the second half.
Latest events from MillerKnoll
- Q3 FY2026 delivered sales growth, margin gains, and strong order momentum despite global risks.MLKN
Q3 202625 Mar 2026 - Margins and EPS rose in Q4 despite lower sales, with a strong outlook for FY2025.MLKN
Q4 20243 Feb 2026 - Order and backlog growth offset lower sales; FY2025 adjusted EPS guidance reaffirmed.MLKN
Q1 202520 Jan 2026 - Q2 net sales up 2.2% to $970.4M, strong Americas growth, adjusted EPS $0.55, guidance narrowed.MLKN
Q2 202510 Jan 2026 - $130M impairment drove Q3 loss, but retail orders and guidance remain strong.MLKN
Q3 202526 Dec 2025 - Profitability improved, global reach expanded, and sustainability advanced; all proposals recommended for approval.MLKN
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, executive pay, auditor, and new incentive plan amid growth focus.MLKN
Proxy Filing1 Dec 2025 - Key votes: director elections, executive pay, auditor ratification, and incentive plan approval.MLKN
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay approval, and auditor ratification.MLKN
Proxy Filing1 Dec 2025